NCT03346902View on ClinicalTrials.gov

Study of EB-001 in Facial Scar Reduction

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 6, 2018

Primary Completion Date

July 31, 2018

Study Completion Date

October 8, 2018

Conditions
Mohs Surgery
Interventions
DRUG

EB-001

Injection of EB-001 into area of scarring (forehead)

DRUG

0.9% Sodium Chloride Injection

Injection of Saline into area of scarring (forehead)

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Bonti, Inc.

INDUSTRY

NCT03346902 - Study of EB-001 in Facial Scar Reduction | Biotech Hunter | Biotech Hunter